Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis
Yupeng Guan, Haiyun Xiong, Yupeng Feng, Guolong Liao, Tongyu Tong, Jun Pang
Topics & Concepts
MedicineEnzalutamideProstate cancerOncologyInternal medicineDocetaxelAbirateroneLymphocyteCancerNeutrophil to lymphocyte ratioCabazitaxelAndrogen deprivation therapyAndrogen receptorInflammatory Biomarkers in Disease PrognosisProstate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers